PHILADELPHIA, Pennsylvania, May 4 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and medical information, announced today that Dr. David Goldmann has joined Elsevier Health Sciences as Vice President, Editor-in-Chief, First Consult. As Editor-in-Chief, Dr. Goldmann is responsible for developing the overall content strategy and vision and leading the entire content production of First Consult and derivative products.
Michael Hansen, Chief Executive Officer, Elsevier Health Sciences said of the appointment, David's background and expertise will help Elsevier become an even stronger knowledge partner, anticipating clinicians' needs across disciplines and providing accurate, timely, evidence-based answers to their questions.
First Consult is part of the Elsevier Health Sciences Clinical Decision Support group that serves the information needs of healthcare organizations and professionals across disciplines, including healthcare researchers, practitioners, providers and payors. First Consult is an authoritative evidence-based and regularly updated clinical information resource for healthcare professionals. Designed for use at the point of care, it provides instant, user-friendly access to the latest information on evaluation, diagnosis, clinical management, prognosis and prevention.
Dr. Goldmann brings a wealth of experience in the medical field. He is an internist and Associate Professor of Medicine at the University of Pennsylvania and has held a number of editorial positions at the American College of Physicians (ACP), where he was Editor-in-Chief of the Physicians' Information and Education Resource (PIER), an evidence-based, electronic medical knowledge resource; Associate, Deputy and Senior Deputy Editor with the Journal Annals of Internal Medicine; and Consulting Editor to ACP Internist and the ACP Foundation HEALTH TiPS patient education program.
Dr. Goldmann was educated at Harvard College, Harvard Medical School and University of Sussex.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tom Reller Director, Corporate Relations +1-212-462-1912 T.Reller@Elsevier.com
Tom Reller, Director, Corporate Relations, +1-212-462-1912, T.Reller@Elsevier.com